SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Natus Medical Inc. – ‘PREM14A’ for 5/23/22 – ‘EX-FILING FEES’

On:  Monday, 5/23/22, at 7:01am ET   ·   For:  5/23/22   ·   Accession #:  1140361-22-20166   ·   File #:  0-33001

5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/23/22  Natus Medical Inc.                PREM14A     5/23/22    2:2.4M                                   Edgarfilings Ltd.

Preliminary Proxy Statement – Merger or Acquisition   —   Schedule 14A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: PREM14A     Preliminary Proxy Statement - Merger or             HTML   2.03M 
                Acquisition                                                      
 2: EX-FILING FEES  Filing Fees Table                               HTML     11K 


‘EX-FILING FEES’   —   Filing Fees Table


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

Exhibit 107

CALCULATION OF FILING FEE TABLES

Schedule 14A
(Form Type)

Natus Medical Incorporated
(Exact Name of Registrant as Specified in its Charter)

Table 1: Transaction Valuation

 
Proposed Maximum
Aggregate Value of
Transaction
 
Fee rate
 
Amount of
Filing Fee
 
Fees to be Paid
$
1,196,399,507.02
(1)
.0000927
 
$
110,907
(2)
Fees Previously Paid
$
0
     
$
0
 
Total Transaction Valuation
$
1,196,399,507.02
           
Total Fees Due for Filing
         
$
110,907
 
Total Fees Previously Paid
         
$
0
 
Total Fee Offsets
         
$
0
 
Net Fee Due
         
$
110,907
 

(1)
Aggregate number of securities to which transaction applies: As of May 16, 2022, the maximum number of shares of common stock to which this transaction applies is estimated to be 35,818,082, which consists of (a) 34,582,882 shares of common stock (including company restricted stock) entitled to receive the per share merger consideration of $33.50; (b) 169,548 shares of common stock underlying company stock options entitled to receive the per share merger consideration of $33.50 minus any applicable exercise price; and (c) 1,065,652 shares of common stock underlying outstanding restricted stock units, which may be entitled to receive the per share merger consideration of $33.50.

(2)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): Estimated solely for the purposes of calculating the filing fee, as of May 16, 2022, the underlying value of the transaction was calculated based on the sum of (a) the product of 34,582,882  shares of common stock (including company restricted stock) and the per share merger consideration of $33.50; (b) the product of 169,548 shares of common stock underlying company stock options and $12.82 (which is the difference between the per share merger consideration of $33.50 and the weighted average exercise price of $20.68); and (c) the product of 1,065,652 shares of common stock underlying outstanding restricted stock units and the per share merger consideration of $33.50. In accordance with Section 14(g) of the Securities Exchange Act of 1934, as amended, the filing fee was determined by multiplying the sum calculated in the preceding sentence by .0000927.




Dates Referenced Herein

This ‘PREM14A’ Filing    Date    Other Filings
Filed on / For Period end:5/23/22None on these Dates
5/16/22
 List all Filings 


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/22  Natus Medical Inc.                10-Q        3/31/22   73:5.2M
 4/18/22  Natus Medical Inc.                8-K:1,5,8,9 4/17/22   13:1.2M                                   Davis Polk & … LLP 01/FA
 2/25/22  Natus Medical Inc.                10-K       12/31/21  108:11M
 2/24/22  Natus Medical Inc.                8-K:2,5,9   2/24/22   11:608K
 1/10/22  Natus Medical Inc.                8-K:2,9     1/10/22   11:196K
Top
Filing Submission 0001140361-22-020166   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 5:49:05.1pm ET